Wordt geladen...
SUN-418 An Uncommon Case of Anti-PD1 Agent Induced Secondary Adrenal Insufficiency
Introduction - Nivolumab is a monoclonal anti-programmed cell death receptor 1(PD1) antibody approved for the treatment of unresectable or metastatic melanoma and is known to be associated with a wide spectrum of endocrinologic derangements. The objective of this report is to describe a case of symp...
Bewaard in:
| Gepubliceerd in: | J Endocr Soc |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Endocrine Society
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553168/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-418 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|